Search

Your search keyword '"Hershberger, Ray E."' showing total 592 results

Search Constraints

Start Over You searched for: Author "Hershberger, Ray E." Remove constraint Author: "Hershberger, Ray E."
592 results on '"Hershberger, Ray E."'

Search Results

1. The GENESIS database and tools: A decade of discovery in Mendelian genomics

4. Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions

5. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

8. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study

9. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study

11. Dilated Cardiomyopathy

12. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

13. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

14. Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel

18. Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

19. Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future

23. Author response: A human mitofusin 2 mutation can cause mitophagic cardiomyopathy

25. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives

26. Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions

28. Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions

29. Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions

30. Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

31. Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

32. Dilated cardiomyopathy

34. Efficacy and Safety of ARRY-371797 in LMNA -Related Dilated Cardiomyopathy: A Phase 2 Study

35. Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene

36. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

37. Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy

39. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee

40. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee

41. A human mitofusin 2 mutation causes mitophagic cardiomyopathy

42. Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

43. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

44. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study

45. Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research

47. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death

48. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study

50. Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

Catalog

Books, media, physical & digital resources